AstraZeneca

New data finds AstraZeneca booster generates higher antibodies against Omicron
AstraZeneca says its antibody drug Evusheld can fight Omicron variant
Oxford study supports AstraZeneca for third dose against Omicron
AstraZeneca vaccine effect wanes in 3 months: Study
EU regulator begins real-time review of Valneva's COVID-19 shot
India's Serum Institute resumes exports of AstraZeneca shot to COVAX facility
Read More
DT next
www.dtnext.in